Drug shortages raise resistance risk
More than 2,000 TB patients in the district have started a six-month course of TB treatment, and an estimated 1,300 HIV-positive patients receive their regular monthly supply of ARVs from Gulu’s largest hospital.
Interruption of either HIV or TB treatment can lead to the development of resistant strains of these diseases, which are much more difficult to treat and require costly second-line drugs.
“Some patients under TB treatment are on expired drugs; even HIV-positive patients suffering from malaria have to buy drugs from clinics in town,” said Angelo Ojera, the HIV focal point in Gulu District.
One patient waiting at a local hospital told IRIN/PlusNews she only had drugs for one month and was anxious about getting a refill: “We pray that the drugs come in time, otherwise our health will deteriorate; I am worried.”
Poor management of the drug supply chain regularly causes shortages of essential medicines in Uganda.
The government has blamed the current shortage of TB medication in many parts of the country on delays in the disbursement of money from the Global Fund to fight AIDS, Tuberculosis and Malaria.
The health ministry has purchased drugs from neighbouring Kenya as a stop-gap measure and the recent opening of a local drug manufacturing plant is expected to improve the supply of ARVs.
This feature is used with permission from IRIN/PlusNews – www.plusnews.org
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Drug shortages raise resistance risk
by Health-e News, Health-e News
April 20, 2009